Joel Greenblatt’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$63.2K Buy
+15,920
New +$66.5K ﹤0.01% 1852
2026
Q2
– Sell
-10,657
Closed -$37.4K – 1851
2026
Q1
$37.4K Buy
+10,657
New +$43.7K ﹤0.01% 1743
2024
Q4
– Sell
-23,766
Closed -$97.9K – 1470
2024
Q3
$97.9K Sell
23,766
-36,394
-60% -$196K ﹤0.01% 1375
2024
Q2
$392K Sell
60,160
-13,794
-19% -$97.6K 0.01% 1154
2024
Q1
$644K Buy
73,954
+11,903
+19% +$144K 0.01% 968
2023
Q4
$710K Buy
62,051
+40,672
+190% +$402K 0.01% 887
2023
Q3
$206K Sell
21,379
-71,663
-77% -$702K ﹤0.01% 1238
2023
Q2
$990K Sell
93,042
-18,817
-17% -$202K 0.02% 773
2023
Q1
$1.18M Buy
111,859
+36,537
+49% +$409K 0.03% 702
2022
Q4
$933K Sell
75,322
-37,240
-33% -$422K 0.03% 705
2022
Q3
$1.17M Buy
112,562
+68,247
+154% +$774K 0.03% 600
2022
Q2
$511K Sell
44,315
-46,671
-51% -$550K 0.02% 778
2022
Q1
$1.14M Sell
90,986
-96,666
-52% -$1.11M 0.04% 522
2021
Q4
$2.19M Buy
187,652
+77,582
+70% +$952K 0.07% 327
2021
Q3
$1.44M Buy
110,070
+15,440
+16% +$200K 0.06% 386
2021
Q2
$1.22M Buy
94,630
+76,193
+413% +$872K 0.05% 436
2021
Q1
$206K Buy
18,437
+1,875
+11% +$19.8K 0.01% 945
2020
Q4
$189K Sell
16,562
-38,198
-70% -$418K 0.01% 939
2020
Q3
$493K Buy
54,760
+8,917
+19% +$88.6K 0.02% 737
2020
Q2
$473K Sell
45,843
-35,345
-44% -$362K 0.01% 757
2020
Q1
$819K Sell
81,188
-36,284
-31% -$426K 0.02% 602
2019
Q4
$1.56M Buy
117,472
+86,110
+275% +$949K 0.03% 523
2019
Q3
$269K Buy
31,362
+2,066
+7% +$20.1K ﹤0.01% 938
2019
Q2
$320K Sell
29,296
-30,605
-51% -$343K 0.01% 939
2019
Q1
$679K Buy
59,901
+44,294
+284% +$495K 0.01% 767
2018
Q4
$135K Buy
+15,607
New +$179K ﹤0.01% 951
2017
Q4
– Sell
-40,971
Closed -$541K – 992
2017
Q3
$541K Sell
40,971
-170,312
-81% -$2.34M 0.01% 686
2017
Q2
$3.34M Sell
211,283
-222,200
-51% -$3.23M 0.05% 438
2017
Q1
$6.19M Buy
433,483
+276,874
+177% +$3.79M 0.08% 344
2016
Q4
$2M Sell
156,609
-20,074
-11% -$254K 0.03% 511
2016
Q3
$2.35M Buy
176,683
+16,901
+11% +$198K 0.03% 471
2016
Q2
$1.75M Buy
+159,782
New +$1.56M 0.02% 541
2014
Q3
– Sell
-33,180
Closed -$426K – 1028
2014
Q2
$426K Buy
+33,180
New +$361K 0.01% 807

Other funds holding IRWD

Joel Greenblatt's IRWD Position: Q3 2026 in Review

Joel Greenblatt opened a new position in Ironwood Pharmaceuticals (IRWD) in Q3 2026: 15,920 shares worth $63.2K. The stake represents ﹤0.01% of the portfolio and ranks #1852 among its holdings. This is a return to the name: Joel Greenblatt previously reported a position in IRWD as recently as Q1 2026.

Joel Greenblatt first reported a position in IRWD in Q2 2014 and has held it in 33 quarters since. The position peaked at $6.19M in Q1 2017. 233 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • Joel Greenblatt held 15,920 shares of Ironwood Pharmaceuticals worth $63.2K as of Q3 2026.
  • Ironwood Pharmaceuticals was a new Joel Greenblatt position in Q3 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1852 holding.
  • Joel Greenblatt first reported a position in Ironwood Pharmaceuticals in Q2 2014 and has held it in 33 quarters since.
  • Joel Greenblatt's Ironwood Pharmaceuticals position peaked at $6.19M in Q1 2017.
  • 233 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.